IE
QNRX

Israel Englander’s Quoin Pharmaceuticals QNRX Stock Holding History

Israel Englander’s Portfolio QNRX Stock Details QNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$544K Buy
112,323
+36,076
+47% +$195K ﹤0.01% 4725
2026
Q1 		$503K Buy
76,247
+1,430
+2% +$13K ﹤0.01% 4766
2025
Q4 		$1.08M Buy
+74,817
New +$1.02M ﹤0.01% 4430

Other funds holding QNRX

DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.89B AUM 55.94% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

Israel Englander's QNRX Position: Q2 2026 in Review

Israel Englander increased its Quoin Pharmaceuticals (QNRX) stake by 47% in Q2 2026, buying an estimated $195K and bringing the position to 112,323 shares worth $544K. The position accounts for ﹤0.01% of the portfolio, ranked #4725.

Israel Englander first reported a position in QNRX in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.08M in Q4 2025. 20 funds tracked by Wall St. Rank hold QNRX as of Q2 2026.

  • Israel Englander held 112,323 shares of Quoin Pharmaceuticals worth $544K as of Q2 2026.
  • Israel Englander bought 36,076 Quoin Pharmaceuticals shares in Q2 2026, an estimated $195K.
  • Quoin Pharmaceuticals made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #4725 holding.
  • Israel Englander first reported a position in Quoin Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Israel Englander's Quoin Pharmaceuticals position peaked at $1.08M in Q4 2025.
  • 20 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.